Latest filing published 13 Jul 2026 for JUPITER NEUROSCIENCES, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Alexander Gustaf Erik Rosen on record concern Jupiter Neurosciences, Inc. We count 2 filings, every one of them for a trade on 2 June 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 13 July 2026: an option exercise, in Jupiter Neurosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations